Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lilly Eli & Co Insider Profile
4 Followers
Lilly Eli & Co, Ten Percent Owner at Zosano Pharma, holds 2.17M shares in Avidity Biosciences (Ticker: RNA), holds 0.00 shares in Elanco Animal Health (Ticker: ELAN), holds 2.90M shares in Zymeworks (Ticker: ZYME).
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
-48.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lilly Eli & Co holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 01, 2011 - Jul 01, 2012
Return:+11.30%
The most profitable trade made by Lilly Eli & Co
Lilly Eli & Co's Trading History
Zosano Pharma
Jan 30, 2015
Ten Percent Owner
Informative Buy
―
$880.91K
CoLucid Pharmaceuticals
Mar 01, 2017
―
Uninformative Buy
896.76M
$2.54M
Leap Therapeutics
―
Ten Percent Owner
―
―
Zymeworks
Feb 04, 2019
Ten Percent Owner
Informative Sell
4.00M
$144.53M
Elanco Animal Health
Mar 11, 2019
Ten Percent Owner
Uninformative Sell
―
$0.00
Avidity Biosciences
Jun 16, 2020
Ten Percent Owner
Uninformative Buy
―
$66.67M
United Therapeutics
Jul 06, 2011
Ten Percent Owner
Uninformative Sell
43.94M
$711.77M
Ionis Pharmaceuticals
―
Ten Percent Owner
―
$127.83M
Daré Bioscience
Apr 15, 2014
Ten Percent Owner
Uninformative Buy
2.43M
$3.18M
List of latest transactions for each holding click on a transaction to see Lilly Eli & Co's performance on stock
You May Also Like
Lilly Eli & Co insider profile FAQ
What is the percentage of profitable transactions made by Lilly Eli & Co?
The percentage of profitable transactions made by Lilly Eli & Co is 50%.
What is the average return per transaction made by Lilly Eli & Co?
The average return per transaction made by Lilly Eli & Co is -48.20%.
What stocks does Lilly Eli & Co hold?
Lilly Eli & Co holds: ZSAN, CLCD, LPTX, ZYME, ELAN, RNA, UTHR, IONS, DARE stocks.
What was Lilly Eli & Co’s latest transaction?
Lilly Eli & Co latest transaction was an Uninformative Buy of ―.
What was Lilly Eli & Co's most profitable transaction?
Lilly Eli & Co’s most profitable transaction was an Informative Sell of UTHR stock on July 1, 2011. The return on the trade was 11.30%.
What is Lilly Eli & Co's role in Zosano Pharma?
Lilly Eli & Co's role in Zosano Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.